LDL cholesterol modulates human CD34+ HSPCs through effects on proliferation and the IL-17 G-CSF axis

Thomas R Cimato1, Beth A Palka, Jennifer K Lang

  • 1Department of Medicine/Division of Cardiovascular Medicine, State University of New York at Buffalo, School of Medicine and Biomedical Sciences, Clinical and Translational Research Center, Buffalo, New York, USA. tcimato@buffalo.edu

Plos One
|August 31, 2013
PubMed

Insights

High LDL cholesterol increases hematopoietic stem/progenitor cells (HSPCs) in humans. This occurs through IL-17/G-CSF mobilization and direct effects on HSPC proliferation, suggesting a link to cardiovascular disease.

Area of Science:

  • Cardiovascular Science
  • Hematology
  • Immunology

Background:

  • Hypercholesterolemia is a key factor in atherosclerosis development.
  • Inflammatory cells implicated in atherosclerosis originate from CD34+ CD45dim Lineage- hematopoietic stem/progenitor cells (HSPCs).
  • High cholesterol in mice mobilizes HSPCs and promotes their differentiation into monocytes and granulocytes.

Purpose of the Study:

  • To investigate the impact of cholesterol levels on human HSPC quantity.
  • To elucidate the mechanisms by which cholesterol influences HSPCs.

Main Methods:

  • A blinded, randomized study involving 12 human subjects treated with statins to modulate lipid levels.
  • Measurement of CD34+ HSPC levels in blood via flow cytometry.
  • Hematopoietic colony-forming assays to confirm HSPC multilineage potential and ELISA for cytokine analysis.

Main Results:

  • A positive correlation was observed between CD34+ HSPC levels and total/LDL cholesterol.
  • LDL cholesterol enhanced HSPC proliferation and cell surface expression of CXCR4, G-CSFR, and CD47.
  • HSPC-mobilizing cytokine G-CSF and its regulator IL-17 positively correlated with LDL cholesterol.

Conclusions:

  • LDL cholesterol positively correlates with human CD34+ HSPC levels.
  • Mechanisms include IL-17-mediated G-CSF mobilization and direct effects on HSPC proliferation.
  • Findings suggest a potential link between HSPCs, cholesterol levels, and cardiovascular disease events.
Abstract